HIGHLIGHTS
- who: Liqun Tu and colleagues from the University of Maryland, United States have published the Article: Incorporation of a TGF-u03b22-inhibiting oligodeoxynucleotide molecular adjuvant into a tumor cell lysate vaccine to enhance antiglioma immunity in mice, in the Journal: (JOURNAL)
- how: In this study TIO3 was used as an adjuvant in a formulation with the glioma TCL which was used to investigate the antitumor effects of TGF-b2 inhibition in mouse GL261 glioma models. The results indicated that TIO3-TCL regulates the activation of potent glioma-specific cytotoxic T lymphocytes and prolongs the survival . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.